This inventor holds 1 USPTO granted patent. Top assignee: Hoechst Marion Roussel. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Sachiko Yanagisawa: Innovator in Monoclonal Antibody Development
Introduction
Sachiko Yanagisawa is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her work has implications for various applications in medical research and diagnostics.
Latest Patents
Yanagisawa holds a patent for an anti-human MP52 monoclonal antibody. This innovative mouse anti-human MP52 monoclonal antibody specifically binds to dimeric human MP52 but not to monomeric human MP52. The antibody, which comprises IgG and exhibits high specificity, is obtained by sensitizing mice with human MP52 produced in CHO cells. This antibody is particularly useful for purifying or assaying human MP52 produced by genetic engineering techniques. She has 1 patent to her name.
Career Highlights
Yanagisawa has worked at Hoechst Marion Roussel, where she has been involved in groundbreaking research and development projects. Her expertise in monoclonal antibodies has positioned her as a key figure in her field.
Collaborations
Throughout her career, Yanagisawa has collaborated with notable colleagues, including Hiroshi Kitagawa and Tomofumi Jitsukawa. These collaborations have further enhanced her research and contributed to advancements in biotechnology.
Conclusion
Sachiko Yanagisawa's contributions to the field of monoclonal antibodies exemplify her innovative spirit and dedication to scientific advancement. Her work continues to influence the landscape of biotechnology and medical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile